Scholar Rock Holding Corporation (SRRK)
Last updated: 2026-10-21 18:57:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Scholar Rock Holding Corporation (SRRK) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $42.72, with a market capitalization of $4.90B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $27.07 to $61.76. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$4.90B | |
$41.52 | |
$70.00 | |
$4.33 | |
$41.36 | |
2.41M | |
1.61M | |
-- | |
$61.76 | |
$27.07 | |
-- | |
-- |
Scholar Rock Holding Corporation (SRRK) Stock Price Today
Scholar Rock Holding Corporation (SRRK) is currently trading at $42.72 as of 2026-10-21 18:40:25, up 3.29% ($1.36) from the previous close of $41.36
During today's regular trading session, SRRK has traded between $4.33 and $70.00, with a trading volume of 2.41M shares. The current price is near the middle of today's range.
Scholar Rock Holding Corporation (SRRK) 7-Day Stock Price Change
Over the past seven days, Scholar Rock Holding Corporation (SRRK) moved from $41.94 to $42.72, representing a gain of 1.86% ($0.78).
The stock traded between $38.69 and $42.84 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 1.70 million shares, down versus the previous seven-day period, indicating lower trading activity.
SRRK 52-Week Price Position
Position in Range: 45.1%
SRRK is currently trading at $42.72, placing it 45.1% of the way from its 52-week low of $27.07 to its 52-week high of $61.76. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Scholar Rock Holding Corporation (SRRK)?
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
Scholar Rock Holding Corporation Information
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 289 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Scholar Rock Holding Corporation (SRRK) Stock on MEXC
Eligible investors can buy real shares of Scholar Rock Holding Corporation (SRRK) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Scholar Rock Holding Corporation (SRRK) stock price today?
2.Is SRRK stock going up or down today?
3.What is SRRK pre-market price?
4.What is SRRK after-hours price?
5.Is SRRK stock trading now?
6.Where does SRRK sit relative to its 52-week high and low?
7.What sector is Scholar Rock Holding Corporation in?
8.What is Scholar Rock Holding Corporation's market capitalization and where is it listed?
9.How is SRRK valued in terms of P/E ratio and EPS?
10.Does Scholar Rock Holding Corporation pay a dividend?
Explore More US Stocks
Search Stocks
SRRK Stock Calculator
Estimate the value between SRRK shares and USD.
SRRK Shares to USD
1.00 SRRK shares = 42.72 USD
Calculations are estimates based on the latest available price and are for reference only.


